Effects of AG-348, a Pyruvate Kinase Activator, on Anemia and Hemolysis in Patients with Pyruvate Kinase Deficiency: Data from the DRIVE PK StudyRachael F. Grace, Bertil Glader, D. Mark Layton et al.|Blood|2016Cited by 6